19029822

Source:http://linkedlifedata.com/resource/pubmed/id/19029822

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0332183, umls-concept:C0332466, umls-concept:C0376358, umls-concept:C0599755, umls-concept:C1276441, umls-concept:C1441672, umls-concept:C2607921
pubmed:issue	2
pubmed:dateCreated	2009-3-2
pubmed:abstractText	TMPRSS2-ERG gene fusion was recently reported as the most common gene rearrangement in prostate cancer (PCA).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101137842
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/ERG protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion, http://linkedlifedata.com/resource/pubmed/chemical/Serine Endopeptidases, http://linkedlifedata.com/resource/pubmed/chemical/TMPRSS2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1555-8576
pubmed:author	pubmed-author:BismarTarek ATA, pubmed-author:CorcosJacquesJ, pubmed-author:DarnelAndrew DAD, pubmed-author:LafargueChristopher JCJ, pubmed-author:VollmerRobin TRT
pubmed:issnType	Electronic
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	125-30
pubmed:meshHeading	pubmed-meshheading:19029822-Adult, pubmed-meshheading:19029822-Aged, pubmed-meshheading:19029822-Aged, 80 and over, pubmed-meshheading:19029822-Canada, pubmed-meshheading:19029822-Cohort Studies, pubmed-meshheading:19029822-Disease-Free Survival, pubmed-meshheading:19029822-Follow-Up Studies, pubmed-meshheading:19029822-Humans, pubmed-meshheading:19029822-In Situ Hybridization, Fluorescence, pubmed-meshheading:19029822-Incidence, pubmed-meshheading:19029822-Male, pubmed-meshheading:19029822-Middle Aged, pubmed-meshheading:19029822-Oncogene Proteins, Fusion, pubmed-meshheading:19029822-Prostatectomy, pubmed-meshheading:19029822-Prostatic Neoplasms, pubmed-meshheading:19029822-Regression Analysis, pubmed-meshheading:19029822-Serine Endopeptidases, pubmed-meshheading:19029822-Time Factors, pubmed-meshheading:19029822-Trans-Activators, pubmed-meshheading:19029822-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort.
pubmed:affiliation	Department of Pathology, McGill University and Jewish General Hospital, Montreal, QC, CA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't